Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cervical Cancer: early-phase trial registry
73 of 151 indexed Cervical Cancer trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #76 of 28,707 conditions by registered trial count.
151 US clinical trials · 73 currently recruiting · #76 of 28,707 conditions by registered trial count
Cervical Cancer: 151 US clinical trials tracked, 73 recruiting.
Cervical Cancer is the subject of 151 registered US clinical trials on ClinicalTrials.gov, 73 of them currently open to new participants. 8 are in Phase 3-4 (later-stage) and 78 in Phase 1-2 (earlier-stage). The most active sponsor is M.D. Anderson Cancer Center, running 11 of these trials.
Enrollment posture brief
Registry condition cervical-cancer
OPEN 73 | RECR 48% | LATE 8 | EARLY 78 | RANK #76 | SPON 11
Volume-matched condition peers
Nearest open-share peer: Chronic Graft Versus Host Disease (48% recruiting · 31 trials)
Cervical Cancer lists 73 open slots (48% of 151 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Cervical Cancer on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Cervical Cancer is recruiting above its size-band peers.
73 of 151 indexed trials (48.3%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Cervical Cancer trials is spread across many organizations.
M.D. Anderson Cancer Center accounts for 11 of 151 trials (7.3%). 101 distinct sponsors appear on at least one study for this condition label.
-
Typical Cervical Cancer enrolment sits around 100 participants.
Median target enrolment is 100 among the 145 trials that report a genuine target (sentinel values excluded). 72 of those (49.7%) plan for fewer than 100 participants.
-
Cervical Cancer research is mostly interventional.
131 interventional and 20 observational studies make up this index (86.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 48 |
| Phase 2 | 30 |
| Phase 3 | 7 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Cervical Cancer records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Cervical Cancer trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Cervical Cancer page
151 registered trials, 73 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 73 Cervical Cancer trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- M.D. Anderson Cancer Center sponsors the most Cervical Cancer trials on record, review their full trial history before evaluating a specific study. See M.D. Anderson Cancer Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cervical Cancer condition card totals 151 registered trials; most-linked intervention Pembrolizumab; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.